Samir H Moussa
5PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Apr 10, 2024
Clinical Outcomes for Patients With Monomicrobial vs Polymicrobial Acinetobacter baumannii-calcoaceticus Complex Infections Treated With Sulbactam-Durlobactam or Colistin: A Subset Analysis From a Phase 3 Clinical Trial.Sarah M McLeod, Alita A Miller, Khurram Rana
|Apr 03, 2024
Characterization of Acinetobacter baumannii-calcoaceticus complex isolates and microbiological outcome for patients treated with sulbactam-durlobactam in a phase 3 trial (ATTACK).Alita A Miller, Samir H Moussa, Sarah M McLeod
|Oct 16, 2023
Molecular drivers of resistance to sulbactam-durlobactam in contemporary clinical isolates of Acinetobacter baumannii.Samir H Moussa, Adam B Shapiro, Sarah M McLeod
|Jul 01, 2017
ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii.Thomas F Durand-Réville, Satenig Guler, Janelle Comita-Prevoir
Pageof 1